反応式
[CH3:1][CH:2]([CH3:25])[C:3](=O)[C:4]#[C:5][C:6]1[CH:7]=[CH:8][C:9]2[N:10]([C:12]([CH2:15][NH:16][C:17](=[O:23])[O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[N:13][N:14]=2)[N:11]=1.[NH2:26]OS(O)(=O)=O.C(=O)(O)[O-].[Na+].[SH-:37].[Na+]>O.O1CCOCC1>[CH:2]([C:3]1[CH:4]=[C:5]([C:6]2[CH:7]=[CH:8][C:9]3[N:10]([C:12]([CH2:15][NH:16][C:17](=[O:23])[O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[N:13][N:14]=3)[N:11]=2)[S:37][N:26]=1)([CH3:25])[CH3:1]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
反応条件
- 温度
- 0 °C
実験手順
An aqueous mixture of tert-butyl (6-(4-methyl-3-oxopent-1-ynyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methylcarbamate (0.800 g, 2.33 mmol) and hydroxylamine-O-sulfonic acid (0.263 g, 2.33 mol) in water (8.0 mL) and 1,4-dioxane (8.0 mL) was stirred at 0° C. until complete consumption of the organic starting material was observed. The mixture was then carefully treated with solid sodium bicarbonate (0.196 g, 2.33 mmol), followed by treatment with 1.4 M aqueous sodium hydrosulfide (1.83 ml, 2.56 mmol). The reaction was stirred at room temperature overnight. The reaction mixture was diluted with water (20 mL) and extracted with DCM (40 mL), dried over sodium sulfate, filtered and concentrated in vacuo. The concentrated crude material was dissolved in minimal DCM and was purified via MPLC (eluting with 0-10% MeOH/NH4OH in DCM) to yield tert-butyl (6-(3-isopropylisothiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methylcarbamate (0.196 g, 22.5% yield) with 82% purity. MS (ESI pos. ion) m/z: 433.0 (M+H). Calc'd Exact Mass for C21H20N8OS: 432.51.
後処理
- stirringThe reaction was stirred at room temperature overnight
- extractionextracted with DCM (40 mL)
- dry with materialdried over sodium sulfate
- filtrationfiltered
- concentrationconcentrated in vacuo
- concentrationThe concentrated crude material
- dissolutionwas dissolved in minimal DCM
- customwas purified via MPLC (eluting with 0-10% MeOH/NH4OH in DCM)
出典と根拠
- ORDレコード
- ord-84b100fdd9184ffd8bde5a7439fd78ed
- 出典データセット
- uspto-grants-2013_09
- 特許番号
- US08524900B2
関連ノート
読み込み中…